Cirrhosis Due to Hepatitis B
8
2
4
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
25%
2 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (8)
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Liver Cirrhosis Network Cohort Study
Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer
TIPS for Platinum-Related Porto-Sinusoidal Vascular Disease With Variceal Bleeding
Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)
Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis
The Efficacy and Safety of TAF vs Other NAs in Patients With LVL
A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated Cirrhosis